NCT06754059
- Conditions
- HER2-positive Breast Cancer
- Locations
-
- Fujian Union Medical College Hospital Fuzhou, Fujian, China
Clinical trial condition
HER2-positive Breast Cancer
Explore clinical trials studying HER2-positive Breast Cancer. Study availability and eligibility vary by location and protocol.
207 public trials
81 recruiting studies
HER2-positive Breast Cancer trial results
NCT06276868
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +10 more
- Locations
-
- Henan cacer hospital Henan, China
NCT06722612
- Conditions
- HER2-positive Breast Cancer
- Locations
-
- Peking University People's Hospital Beijing, Beijing Municipality, China
NCT06722599
- Conditions
- HER2-positive Breast Cancer
- Locations
-
- Peking University People's Hospital Beijing, Beijing Municipality, China
NCT06711068
- Conditions
- HER2-positive Breast Cancer
- Locations
-
- Peking University People's Hospital Beijing, Beijing Municipality, China
Recruiting
Taxane Combined Targeted Therapy for Low-risk HER2 Positive and Lymph Node Negative Breast Cancer
NCT06711055
- Conditions
- HER2-positive Breast Cancer
- Locations
-
- Peking University People's Hospital Beijing, Beijing Municipality, China
NCT06700369
- Conditions
- HER2-positive Breast Cancer
- Locations
-
- Peking University People's Hospital Beijing, Beijing Municipality, China
NCT06693024
- Conditions
- HER2-positive Breast Cancer
- Locations
-
- Peking University People's Hospital Beijing, Beijing Municipality, China
Recruiting
Adjuvant Therapy Choice for Non-pCR HER2 Positive Early Breast Cancer After Neoadjuvant Therapy
NCT06693037
- Conditions
- HER2-positive Breast Cancer
- Locations
-
- Peking University People's Hospital Beijing, Beijing Municipality, China
NCT06479460
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
- Jiangsu Province Hospital Nanjing, Jiangsu, China